At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just the current, but also the future challenges. Together, let’s bring your next medicine to life.
Our story begins in 2004 with Margret Böck and Dr. Hanno Wachernig in Meerbusch, who founded Particle Metrix to offer counselling work for particle characterization. Today, we develop and manufacture our devices in Inning and sell them worldwide. Beside technical nanoparticles, biomedical and clinical applications play a central role. We specialized in the characterization of extracellular vesicles, exosomes, liposomes and viruses, using both scatter and fluorescence based methods and focusing on determining the size and concentration as well as measuring zeta potential of particles in the nanometer scale.
RoosterBio manufactures high-volume, well-characterized hMSCs paired with bioprocess media systems and reagents that radically simplify production of Extracellular Vesicles (EVs). Having a consistent, ready-supply of hMSC and EVs enables RoosterBio product users to leap ahead in research, product development, and manufacturing and enter clinical trials much faster and at much lower cost than older, slower, more expensive methods.